CS

Chetan Singh Mandloi

Active Director Director DIN 09032120
DIN 09032120 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chetan Singh Mandloi

Data last updated:

Chetan Singh Mandloi is a Director at Cure21 Bioscience Private Limited (since 2021). The company operates in Chemicals.

DIN 09032120
Primary Designation Director
Industry Chemicals
First Appointment 16 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cure21 Bioscience Private Limited U24230MP2021PTC054531
Director16 Jan 20212021Active

Board colleagues of Chetan Singh Mandloi

NameDINCompanyDesignation
Apurva Gopaldas Vaishnav07605047Cure21 Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cure21 Bioscience Private Limited
Premium access

Shareholding and investment profile for Chetan Singh Mandloi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Singh Mandloi

Chetan Singh Mandloi currently holds 1 directorship: Cure21 Bioscience Private Limited (Director, since 16 Jan 2021).

Chetan Singh Mandloi was first appointed on 16 Jan 2021 as Director at Cure21 Bioscience Private Limited.

The current boards of Chetan Singh Mandloi's companies include Apurva Gopaldas Vaishnav (Cure21 Bioscience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available